The Kanabo share price: is now the time to buy?

The Kanabo share price surged by more than 500% after its IPO! Today it’s much lower. Could this be a buying opportunity? Zaven Boyrazian investigates.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Kanabo Group (LSE:KNB) share price exploded in its first week of trading last month, increasing from its issue price of 6.5p to a high of just over 40p. That’s more than a 500% rise in a matter of days!

Since then, the Kanabo share price has fallen down to 23p. But is this a buying opportunity for my growth portfolio? Let’s take a look.

What does Kanabo Group do?

Kanabo develops and manufactures CBD-based products and inhalers. The business has been around for a couple of years but has only recently begun selling anything.

It is currently in the middle of a three-month pilot scheme designed to measure several key performance indicators concerning the sale of its products. Specifically testing general demand, supply chain effectiveness, and quality controls.

But this is not the long-term strategy of the business. Using the income generated from selling retail products, Kanabo intends to produce a range of unlicensed medical cannabis oils to be used with its vaporisation devices.

If successful, this could form a viable razor-and-blades business model that could cause the Kanabo share price to rise even higher. But there are plenty of risks to consider.

The risks of investing early

Just like many start-ups, Kanabo has yet to create any proven products or establish a well-known brand. The results from its pilot scheme have revealed some level of customer retention, with around 40% coming back to buy more. While this is undoubtedly a promising start, I believe it needs to be much higher. I’ll be closely watching whether management can boost this metric over time.

This is especially important since the medical cannabis oil products that the company intends to make are going to be unlicensed. Why does that matter? An unlicensed medication doesn’t require extensive clinical trials nor regulatory approval before becoming publically available. This significantly reduces development costs. But consequently, it also means that Kanabo’s oils will never be prescribed by the NHS, as there are already existing licensed products available that fulfil the same role.

Naturally, this creates a significant barrier to entry for Kanabo’s future medical products. And so, the company will have to rely on the reputation of its existing brands to drive sales. Given it has yet to build any substantial reputation, this may be tough.

The Kanabo share price has plenty of risks ahead

Can the Kanabo share price climb higher?

The medical cannabis industry is growing rapidly by almost 18% a year. And as more countries legalise medical marijuana, this growth may accelerate. This ultimately creates an excellent environment for Kanabo to thrive in. However, let’s not forget there are plenty of other companies trying to do the same thing.

Personally, it’s too soon for me to add Kanabo to my portfolio, even at its current share price. But I’ll definitely be keeping an eye on it.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian does not own shares in Kanabo Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

With a P/E ratio of 9, is the Aviva share price a bargain?

Christopher Ruane looks at the Aviva share price and considers some strengths and weaknesses of the FTSE 100 insurance business.

Read more »

Surprised Black girl holding teddy bear toy on Christmas
US Stock

Is it too late to buy growth stock Shopify after its 25% pop?

Up more than 40% this year, Shopify is on fire at the moment. Here, Edward Sheldon explains how he’d play…

Read more »

Investing Articles

Investors should consider buying this energy AIM stock, up 50% in the past year

AIM stock Afentra has seen a stellar price rise in 12 months to November. I believe there may be room…

Read more »

Investing Articles

2 ISA shares to consider for a large passive income!

Looking for dividend shares to buy in a Stocks and Shares ISA or Lifetime ISA? Royston Wild reveals two of…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

A Bitcoin investment that can be held inside a Stocks and Shares ISA or SIPP

UK investors can’t buy Bitcoin ETFs for their investment accounts or SIPPs due to FCA regulation. This stock could be…

Read more »

Entrepreneur on the phone.
Investing Articles

As the Vodafone share price slides 6% on lacklustre H1 results, what does the future hold?

After posting moderate results this morning, Vodafone saw its share price sink further, erasing this year's gains. Our writer looks…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing For Beginners

If I’d invested £5k in a FTSE tracker fund after the pandemic crash, here’s what I’d have now

Jon Smith explains the extent of his potential gains if he'd invested in a FTSE tracker fund during the Covid…

Read more »

Investing Articles

2 top shares I’ve bought for my Stocks and Shares ISA in November

This writer reveals a pair of fast-growing businesses that he's recently added to his Stocks and Shares ISA for the…

Read more »